PubMed Health⌕ Search

Biomedical subjects

M R Mingiardi

Publications and source records attributed to M R Mingiardi.

8 recordsLinked to original sources
PubMed1996

Biological studies on 1,2-benzisothiazole derivatives VI Antimicrobial activity of 1,2-benzisothiazole and 1,2-benzisothiazolin-3-one derivatives and of some corresponding 1,2-benzisoxazoles.

Numerous 1,2-benzisothiazole and 1,2-benzisothiazolin-3-one derivatives, variously substituted in the different positions of the molecule, were tested for their in vitro antimicrobial activity. Some corresponding 1,2-benzisoxazoles and 1,2-benzisoxazolin-3-ones were also considered. Several compounds possess a potent and broad antibacterial and antifungal activity, particularly against Gram positive microorganisms, yeasts and dermatophytes. 1,2-Benzisothiazolin-3-ones were found to be the most active substances. On the contrary, the benzisoxazoles and the benzisoxazolin-3-ones considered were devoid of activity. The results obtained are discussed on the basis of structure-activity relationships.

Anti-Bacterial Agents↗
PubMed1992

Pharmacological properties of new 1,2-benzisothiazolyloxypropanolamines on cardiac and tracheal beta-receptors.

This paper reports the pharmacological assessment of beta-blocking properties of new benzisothiazole and benzisoxazole derivatives, substituted in position 3-, 5- or 7- with the oxypropanolaminic side chain (I-VI), to of which contain the -OCH3 group in position 3- (III, V) in comparison with propranolol. The results, obtained on isoprenaline-induced chronotropic response of rat isolated atria and on isoprenaline-induced relaxation of guinea-pig tracheal strips precontracted by carbachol, suggest that the compounds (I, II, IV, VI), at variance with the methoxy-substituted (III, V), possess a beta 1-blocking activity 4-300 times lower than propranolol. pA2 values drop from 8.36 to 7.56 and 7.04 from the relative compounds substituted in position 7- (IV), 3- (I) and 5- (II), thus indicating that the position of the oxypropanolaminic chain in the benzisothiazole ring affects the ability of the molecules to interact with the beta 1-adrenoceptor. Furthermore, benzisothiazole rather than benzisoxazole ring seems to facilitate the drug-beta 1 adrenoceptor interaction, the compound (I) displaying a 10-fold higher affinity than compound (VI).

Adrenergic beta-Antagonists↗
PubMed1991

Biological studies on 1,2-benzisothiazole derivatives. IV. Relationships between chemical structure and genotoxicity.

This paper describes in vitro evaluation by Bacillus subtilis rec-assay and Salmonella-microsome assay of the genotoxic properties of some 1,2-benzisothiazole and 1,2-benzisothiazolin-3-one derivatives, containing groups (aromatic nitro, aromatic amino, epoxide groups) often associated with mutagenic properties and defined as "alerting groups". Compounds 2, 3, 4, 7, 8, 9, 11, 14, 16, 20, 21 and 22 exhibited DNA-damaging activity. The Salmonella-microsome assay confirmed the genotoxic activity of these compounds, which was also demonstrated for compounds 5, 6, 10, 12, 13, 15, 17, 18, 19, 25 and 27. Relationships between chemical structure and genotoxic activity showed that all the 1,2-benzisothiazole derivatives containing an alerting group were active. On the contrary, among 1,2-benzisothiazolin-3-one derivatives, compounds 24 and 26 were non-mutagenic, although an alerting group was present in the molecule.

Animals↗
PubMed1983

[Imidazopyrimidines with cytokinin activity].

Some imidazopyrimidines structurally analogous to the corresponding natural kinetics (adenine, benzyladenine, kinetic) were prepared and tested for cytokinin-like activity. Among the compounds tested for ability to retard degradation of the photosynthetic system, the 7-chloroderivatives (II-III) showed activity comparable with that of natural kinetic and confirm the chlorine function as a potentiator of biological activity.

Chlorophyll↗